Filing Details
- Accession Number:
- 0001178913-22-004098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 16:56:23
- Reporting Period:
- 2022-11-16
- Accepted Time:
- 2022-11-17 16:56:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534248 | Chemomab Therapeutics Ltd. | CMMB | Pharmaceutical Preparations (2834) | 813676773 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1851069 | Adi George Mor | 15 Kafrisin St. Tel Aviv L3 6901658 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Disposition | 2022-11-16 | 324,775 | $2.08 | 324,775 | No | 4 | S | Direct | |
American Depositary Shares | Disposition | 2022-11-16 | 257,248 | $2.08 | 257,247 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2018-03-15 | 131,698 | $0.00 | 131,698 | $1.49 |
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2016-10-28 | 33,725 | $0.00 | 33,725 | $0.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
131,698 | 2028-03-15 | No | 4 | A | Direct | |
33,725 | 2026-10-27 | No | 4 | A | Indirect |
Footnotes
- Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- The reported price in Column 4 is a weighted average price pursuant to the share purchase agreement between Adi Mor, Kobi George, and the Issuer, as disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 16, 2022.
- No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- These options have vested and are exercisable as of the date hereof.
- These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.